Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 02 - 28    crawled time : 14:30    save search

WidePoint Expands Portfolio of Secure Technology Management Service Offerings
Published: 2022-02-28 (Crawled : 14:30) - widepoint.com
WYY 4 | $2.18 -2.68% 0.0% 31K twitter stocktwits trandingview |
Technology Services
| | O: 4.01% H: 0.0% C: -3.65%

offering technology
Vislink Joins Dorna Sports and MotoGP™ at Mobile World Congress Barcelona 2022
Published: 2022-02-28 (Crawled : 14:30) - vislink.com
VISL | $4.115 23.84% 19.25% 150K twitter stocktwits trandingview |
Electronic Technology
| | O: -0.11% H: 5.49% C: 1.65%

mobile cel
Teknova Announces Preliminary Revenue of $10.0 to $10.1 Million for the Fourth Quarter 2021Company to participate in two upcoming investor conferences in March 2022
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
TKNO | $2.57 6.64% 6.23% 710 twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.06% H: 10.3% C: 7.46%

conference
ALX Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
ALXO | $12.86 -1.31% -1.32% 330K twitter stocktwits trandingview |
Commercial Services
| | O: -0.77% H: 9.75% C: 8.37%

financial results one report results milestone
GRUPO EL CID RESORTS AND INTERVAL INTERNATIONAL ANNOUNCEMULTI-SITE AFFILIATI …
Published: 2022-02-28 (Crawled : 14:30) - marriottvacationsworldwide.com
VAC 4 | $97.74 0.76% 0.0% 610K twitter stocktwits trandingview |
Consumer Services
| | O: -1.26% H: 0.71% C: 0.19%


AbbVie Seeks New Indication for IMBRUVICA® (ibrutinib) in Pediatric Patients with Chronic Graft Versus Host Disease (cGVHD)
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.0% C: 0.0%

imbruvica disease
WideOpenWest, Inc. to Participate in Upcoming Investor Conferences
Published: 2022-02-28 (Crawled : 14:30) - prnewswire.com
WOW A | $3.58 -1.65% 0.0% 420K twitter stocktwits trandingview |
Communications
| | O: -0.82% H: 1.83% C: 0.53%

conference
Lightpath Opens New Boston Office to Support Rapid Expansion in Massachusetts
Published: 2022-02-28 (Crawled : 14:30) - prnewswire.com
MS 3 d | $86.99 0.93% -0.26% 9.5M twitter stocktwits trandingview |
Finance
| | O: -0.32% H: 0.0% C: 0.0%
ATUS 4 | $2.05 -5.96% 0.0% 1.9M twitter stocktwits trandingview |
Consumer Services
| | O: -0.43% H: 1.04% C: 0.35%

expansion set
Quantemplate Partners with Duck Creek Technologies, allowing reinsurers to seamlessly integrate
Published: 2022-02-28 (Crawled : 14:30) - duckcreek.com
DCT | $18.99 0.0% 0 twitter stocktwits trandingview |
Technology Services
| | O: 1.23% H: 0.0% C: 0.0%


Annexon Biosciences to Participate in the Cowen 42nd Annual Healthcare Conference
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
ANNX P | $5.74 -4.01% -4.18% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -5.54%

health thc conference bioscience
Jounce Therapeutics to Participate in Cowen & Co. 42nd Annual Health Care Conference
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.96% H: 4.46% C: 3.32%
GILD | $67.76 -1.3% -1.31% 7.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.0% H: 0.37% C: 0.25%

health conference therapeutics
NeuBase Therapeutics to Present New Preclinical Data for Myotonic Dystrophy Type 1 Program at the 2022 MDA Clinical & Scientific Conference
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
NBSE | $0.411 -6.31% -6.74% 35K twitter stocktwits trandingview |
Health Technology
| | O: 2.11% H: 9.62% C: 2.07%

program conference therapeutics preclinical pre-clinical
​​What Does Depression Feel Like?
Published: 2022-02-28 (Crawled : 14:30) - brainsway.com
BWAY | $5.22 1.36% 1.34% 34K twitter stocktwits trandingview |
Health Technology
| | O: -2.7% H: 0.0% C: 0.0%

depression
Black Knight’s Optimal Blue Mortgage Lock Data Used to Forecast Short-Term Prepayment Activity, Enhance Behavioral Models
Published: 2022-02-28 (Crawled : 14:30) - blackknightinc.com
CNNE S | $19.99 -1.72% 0.0% 710K twitter stocktwits trandingview |
Finance
| | O: -1.29% H: 4.73% C: 3.15%
BKI | $75.76 0.0% 0 twitter stocktwits trandingview |
Technology Services
| | O: -0.44% H: 1.57% C: -0.02%

blue tga
Nuclear Power Plant and Equipment Market to Reach $58.4 Bn, Globally, by 2030 at 3.5% CAGR: Allied Market Research
Published: 2022-02-28 (Crawled : 14:30) - prnewswire.com
ALSMY | $1.5 -1.78% 570K twitter stocktwits trandingview |
Manufacturing
| | O: -5.41% H: 3.63% C: 0.82%
KEP | $7.505 2.67% 0.0% 170K twitter stocktwits trandingview |
Utilities
| | O: 3.68% H: 1.57% C: 1.25%
BWXT 4 | $93.85 -0.75% 0.0% 620K twitter stocktwits trandingview |
Utilities
| | O: 0.28% H: 7.54% C: 7.42%

research
Zynerba Pharmaceuticals Announces Completion of Enrollment in Phase 2 Trial of Zygel™ in 22q11.2 Deletion SyndromeTopline data from Phase 2 INSPIRE trial expected mid-year 2022
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: -4.76% H: 0.0% C: 0.0%

phase 2 als trial topline enroll zygel
MainStay CBRE Global Infrastructure Megatrends Fund (NYSE: MEGI) Announces Availability of 19(a) Notice
Published: 2022-02-28 (Crawled : 14:30) - prnewswire.com
MEGI | $11.67 -1.02% 0.09% 210K twitter stocktwits trandingview |
| | O: 1.5% H: 0.93% C: -0.6%
CBRE | $86.99 -2.69% 0.0% 1.8M twitter stocktwits trandingview |
Finance
| | O: -2.24% H: 1.96% C: 0.45%

ces
GSE Enters into Convertible Note Agreement
Published: 2022-02-28 (Crawled : 14:30) - prnewswire.com
GVP | $2.92 -2.99% -3.08% 9.8K twitter stocktwits trandingview |
Commercial Services
| | O: 0.76% H: 0.0% C: -3.03%


INVENERGY AND ENERGYRE SECURE OFFSHORE WIND LEASE AWARD AND ANNOUNCE FORMATION OF INVESTOR CONSORTIUM
Published: 2022-02-28 (Crawled : 14:30) - prnewswire.com
BX | $121.17 -1.86% 0.0% 3.3M twitter stocktwits trandingview |
Finance
| | O: -2.3% H: 2.13% C: 1.31%

energy
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Atopic Dermatitis
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M twitter stocktwits trandingview |
Health Technology
| | O: 1.79% H: 0.0% C: 0.0%

lnk0100 als atopic dermatitis ces dermatitis derm 100
Gainers vs Losers
49% 51%

Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M twitter stocktwits trandingview |
Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M twitter stocktwits trandingview |
Health Technology

DYNT | $0.371 -5.12% 43.09% 3.3M twitter stocktwits trandingview |
Health Technology

LGVN P 3 d | $2.94 73.96% 42.52% 57M twitter stocktwits trandingview |

HUBC | $1.94 49.23% 32.99% 73M twitter stocktwits trandingview |
n/a

SPCB | $0.4044 46.52% 31.75% 130M twitter stocktwits trandingview |
Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M twitter stocktwits trandingview |
Health Technology

OMQS | $0.6869 32.1% 24.3% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...

SNPO | $10.555 29.67% 22.88% 4M twitter stocktwits trandingview |

AMBI | $3.72 -26.77% 21.77% 9.8K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.